Alexandre Arcaro

725 total citations
20 papers, 606 citations indexed

About

Alexandre Arcaro is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Alexandre Arcaro has authored 20 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Alexandre Arcaro's work include Cancer, Hypoxia, and Metabolism (7 papers), Neuroblastoma Research and Treatments (4 papers) and Hedgehog Signaling Pathway Studies (3 papers). Alexandre Arcaro is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Neuroblastoma Research and Treatments (4 papers) and Hedgehog Signaling Pathway Studies (3 papers). Alexandre Arcaro collaborates with scholars based in Switzerland, United States and Germany. Alexandre Arcaro's co-authors include Michael A. Grotzer, Tarek Shalaby, Barbara Fischer, Olivier E. Pardo, Julian Downward, Michael J. Seckl, Claudia Meier, André O. von Bueren, Ana Guerreiro Stücklin and Giulio Fiaschetti and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Alexandre Arcaro

20 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Arcaro Switzerland 14 393 209 195 80 60 20 606
Vikash Bhagwandin United States 8 269 0.7× 165 0.8× 225 1.2× 119 1.5× 35 0.6× 9 568
Aizhen Xiao United States 15 393 1.0× 253 1.2× 189 1.0× 90 1.1× 170 2.8× 21 773
Anja Kafka Croatia 13 315 0.8× 125 0.6× 120 0.6× 77 1.0× 82 1.4× 24 536
Eftychia Oikonomou Greece 13 330 0.8× 135 0.6× 273 1.4× 69 0.9× 34 0.6× 16 597
Thomas Strömberg Sweden 12 503 1.3× 151 0.7× 214 1.1× 34 0.4× 59 1.0× 15 744
Chih-Chen Hong Taiwan 11 388 1.0× 180 0.9× 183 0.9× 28 0.3× 41 0.7× 11 667
Balaram Thota India 12 318 0.8× 277 1.3× 110 0.6× 85 1.1× 208 3.5× 15 598
Tao Hai China 12 314 0.8× 234 1.1× 107 0.5× 35 0.4× 31 0.5× 17 523
Frida Abel Sweden 18 419 1.1× 315 1.5× 147 0.8× 75 0.9× 53 0.9× 27 736
Tibor Schomber Switzerland 10 432 1.1× 90 0.4× 253 1.3× 82 1.0× 60 1.0× 18 816

Countries citing papers authored by Alexandre Arcaro

Since Specialization
Citations

This map shows the geographic impact of Alexandre Arcaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Arcaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Arcaro more than expected).

Fields of papers citing papers by Alexandre Arcaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Arcaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Arcaro. The network helps show where Alexandre Arcaro may publish in the future.

Co-authorship network of co-authors of Alexandre Arcaro

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Arcaro. A scholar is included among the top collaborators of Alexandre Arcaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Arcaro. Alexandre Arcaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klukowska‐Rötzler, Jolanta, et al.. (2017). Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis. PLoS ONE. 12(10). e0187308–e0187308. 5 indexed citations
2.
Leni, Zaira, et al.. (2017). 2‐Deoxy‐D‐glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N‐Linked Glycosylation in an Oxygen Tension‐Independent Manner. Oxidative Medicine and Cellular Longevity. 2017(1). 2487297–2487297. 4 indexed citations
3.
4.
Arcaro, Alexandre. (2015). Targeted therapies for small cell lung cancer: Where do we stand?. Critical Reviews in Oncology/Hematology. 95(2). 154–164. 42 indexed citations
5.
Leni, Zaira, Beata Styp‐Rekowska, Gianpaolo Chiriano, et al.. (2014). RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification. Oncotarget. 6(1). 116–129. 17 indexed citations
6.
Arcaro, Alexandre. (2013). Targeting the insulin-like growth factor-1 receptor in human cancer. Frontiers in Pharmacology. 4. 30–30. 88 indexed citations
7.
Leni, Zaira, et al.. (2013). Emerging Metabolic Targets in the Therapy of Hematological Malignancies. BioMed Research International. 2013. 1–12. 13 indexed citations
8.
Ghosal, Abhisek, Lucia Buccarello, Carlos Wotzkow, et al.. (2012). RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance. Oncogene. 32(34). 3944–3953. 19 indexed citations
9.
Christiansen, Ditte G., Tiziana P. Cremona, Tarek Shalaby, et al.. (2012). Novel Agents Targeting the IGF-1R/PI3K Pathway Impair Cell Proliferation and Survival in Subsets of Medulloblastoma and Neuroblastoma. PLoS ONE. 7(10). e47109–e47109. 23 indexed citations
10.
Stücklin, Ana Guerreiro, Sarah Fattet, Alexandra N. Elsing, et al.. (2011). A Sensitized RNA Interference Screen Identifies a Novel Role for the PI3K p110γ Isoform in Medulloblastoma Cell Proliferation and Chemoresistance. Molecular Cancer Research. 9(7). 925–935. 42 indexed citations
11.
Fiaschetti, Giulio, Lucia Abela, Alexandre Arcaro, et al.. (2011). MicroRNA-21 suppression impedes medulloblastoma cell migration. European Journal of Cancer. 47(16). 2479–2490. 58 indexed citations
12.
Bueren, André O. von, Tarek Shalaby, Christoph Oehler‐Jänne, et al.. (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer. 9(1). 10–10. 40 indexed citations
13.
Grotzer, Michael A., Deborah Castelletti, Giulio Fiaschetti, Tarek Shalaby, & Alexandre Arcaro. (2009). Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System. Current Cancer Drug Targets. 9(2). 176–188. 12 indexed citations
14.
Arcaro, Alexandre & Barbara Fischer. (2008). Current Status of Clinical Trials for Small Cell Lung Cancer. Reviews on Recent Clinical Trials. 3(1). 40–61. 42 indexed citations
15.
Bueren, André O. von, Tarek Shalaby, Duncan Stearns, et al.. (2007). Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells. BMC Cancer. 7(1). 19–19. 32 indexed citations
16.
Wahl, Patricia R., Michel Le Hir, Alexander Vogetseder, et al.. (2007). Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease. Nephrology. 12(4). 357–363. 25 indexed citations
17.
Stücklin, Ana Guerreiro, et al.. (2006). IGF-IR: Potential Role in Antitumor Agents. Drug News & Perspectives. 19(5). 261–261. 19 indexed citations
18.
19.
Arcaro, Alexandre, et al.. (2004). 355 Inhibition of human small cell lung cancer growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling. European Journal of Cancer Supplements. 2(8). 107–107. 1 indexed citations
20.
Pardo, Olivier E., Alexandre Arcaro, Rita Lopes, et al.. (2004). Fibroblast Growth Factor 2-Mediated Translational Control of IAPs Blocks Mitochondrial Release of Smac/DIABLO and Apoptosis in Small Cell Lung Cancer Cells. Molecular and Cellular Biology. 24(15). 6887–6887. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vikash Bhagwandin Breakdown of academic impact, for papers by Aizhen Xiao Breakdown of academic impact, for papers by Anja Kafka Breakdown of academic impact, for papers by Eftychia Oikonomou Breakdown of academic impact, for papers by Thomas Strömberg Breakdown of academic impact, for papers by Chih-Chen Hong Breakdown of academic impact, for papers by Balaram Thota Breakdown of academic impact, for papers by Tao Hai Breakdown of academic impact, for papers by Frida Abel Breakdown of academic impact, for papers by Tibor Schomber
Rankless by CCL
2026